|Institutional Source||Beutler Lab|
|Gene Name||mechanistic target of rapamycin kinase|
|Synonyms||RAPT1, FKBP-rapamycin-associated protein FRAP, RAFT1, flat, Frap1, 2610315D21Rik|
|Essential gene?||Essential (E-score: 1.000)|
|Stock #||R4995 (G1)|
|Chromosomal Location||148448611-148557683 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||A to G at 148525752 bp (GRCm38)|
|Amino Acid Change||Aspartic acid to Glycine at position 1572 (D1572G)|
|Ref Sequence||ENSEMBL: ENSMUSP00000099510 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000103221]|
AA Change: D1572G
PolyPhen 2 Score 0.998 (Sensitivity: 0.27; Specificity: 0.99)
AA Change: D1572G
|Meta Mutation Damage Score||0.3189|
|Coding Region Coverage||
|Validation Efficiency||99% (86/87)|
Strain: 3529989; 4820819; 3512186; 5425404; 3052669
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. The ANGPTL7 gene is located in an intron of this gene. [provided by RefSeq, Sep 2008]
PHENOTYPE: Mice homozygous for targeted, gene trap and ENU-induced null alleles exhibit embryonic lethality by E12.5 with abnormal embryogenesis. Mice homozygous for the ENU mutation further exhibit abnormal brain development. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Mtor||
(F):5'- TGAGCATTCCTTGAGCTTCTGC -3'
(R):5'- TGCTGTCAGGATATCTGCAGAC -3'
(F):5'- GCCGCTCAGTCTTTGATGAGAC -3'
(R):5'- GTCAGGATATCTGCAGACCCCAG -3'